Form 4: Edwards Lifesciences Executive Reports Stock Disposals to Cover Tax Obligations
SEC Form 4 Filing
Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences, disposed of shares to cover tax obligations arising from equity awards.
Summary
- On May 3, 2024, Daniel J. Lippis, CVP of JAPAC at Edwards Lifesciences Corp, disposed of 281 shares of common stock at a price of $85.06.
- On May 4, 2024, Mr. Lippis disposed of 291 shares of common stock at a price of $85.25.
- These transactions were reported on a Form 4 filing with the SEC.
- Following these transactions, Mr. Lippis beneficially owns 16,915.7443 shares of Edwards Lifesciences common stock.
Sentiment
Score: 5
Explanation: The document is a routine SEC filing related to stock transactions by an executive. It doesn't contain information that would significantly impact investor sentiment positively or negatively.
Industry Context
Executive stock transactions are a common occurrence and are often related to compensation and tax planning. The transactions themselves don't necessarily indicate a change in the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/03/2024 | Daniel J. Lippis disposed of 281 shares of common stock at $85.06 per share. |
| 05/04/2024 | Daniel J. Lippis disposed of 291 shares of common stock at $85.25 per share. |
| 05/06/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.